Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells

Abstract Background Mesenchymal stem cells (MSCs) have been demonstrated to be effective in treating autoimmune diseases including Sjögren’s syndrome (SS). We aim to compare the effects of MSC transplantation (MSCT) and the role of serum interleukin-12 (IL-12) in SS. Methods IL-12 levels were measur...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bingyu Shi, Jingjing Qi, Genhong Yao, Ruihai Feng, Zhuoya Zhang, Dandan Wang, Chen Chen, Xiaojun Tang, Liwei Lu, Wanjun Chen, Lingyun Sun
Format: Artigo
Langue:Inglês
Publié: BMC 2018-11-01
Collection:Stem Cell Research & Therapy
Sujets:
Mesenchymal stem cells
Sjögren’s syndrome
Interleukin-12
Accès en ligne:http://link.springer.com/article/10.1186/s13287-018-1023-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires